FDA recall D-0150-2025

Product

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Reason for recall

Discoloration

Distribution

Nationwide within the United States

Key facts

Status

Ongoing

Initiation date

2024-11-22

Report date

2024-12-25

Voluntary/Mandated

Voluntary: Firm initiated

Location

Collegeville, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2025